DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Zhang W, Krauwinkel WJJ, Keirns J. et al.
The Effect of Moderate Hepatic Impairment on the Pharmacokinetics of
Ipragliflozin, a Novel Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor.
Clin Drug Investig 2013;
33: 489-496
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.